Phenylacetyl chloride → HCID 5324449、化合物
反応式
[CH3:1][C:2]1[S:6][C:5]([NH:7][CH2:8][C:9]2[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=2)=[N:4][N:3]=1.[C:15]1([CH2:21][C:22](Cl)=[O:23])[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1>N1C=CC=CC=1>[C:9]1([CH2:8][N:7]([C:5]2[S:6][C:2]([CH3:1])=[N:3][N:4]=2)[C:22](=[O:23])[CH2:21][C:15]2[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=2)[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=1参加物
4
実験手順
N-(5-Methyl-1,3,4-thiadiazol-2-yl)-benzylamine (15 g, 0.073 mole) in pyridine (200 ml) was refluxed with phenylacetyl chloride for 6 hours. The pyridine was removed under educed pressure and the residue treated with water and extracted with ether. The ethereal solution was dried, filtered and evaporated to dryness and the residue recrystallised from ethanol to give the title compound, m.p. 128° C.
後処理
- customThe pyridine was removed
- additionthe residue treated with water
- extractionextracted with ether
- customThe ethereal solution was dried
- filtrationfiltered
- customevaporated to dryness
- customthe residue recrystallised from ethanol
出典と根拠
- ORDレコード
- ord-db2c07feefb048ee9746aa08d6125d3f
- 出典データセット
- uspto-grants-1979_06
- 特許番号
- US04158659
反応ノート
読み込み中…